Animal Models and Experimental Medicine(2024年04期)
動物模型與實驗醫(yī)學(xué)(英文)

目 錄

• Cucurbitacins mitigate vascular neointimal hyperplasia by suppressing cyclin A2 expression and inhibiting VSMC proliferation
• Mi R-106a targets ATG7 to inhibit autophagy and angiogenesis after myocardial infarction
• Preliminary study of metabonomic changes during the progression of atherosclerosis in miniature pigs
• Developments in the study of Chinese herbal medicineu0027s assessment index and action mechanism for diabetes mellitus
• Uncovering the impact of alcohol on internal organs and reproductive health: Exploring TLR4/NF-k B and CYP2E1/ROS/Nrf2 pathways
• Against all odds:The road to success in the development of human immune reconstitution mice
• Animal models of tendon calcification:Past, present, and future
• How can we establish animal models of HIV-associated lymphoma?
• Ultra-high-performance liquid chromatography-quadrupole time-of-flight-mass spectrometry-characterized extract of Aerides odorata Lour alleviates paracetamol-induced hepatotoxicity in animal model evidenced by biochemical,molecular, and computational studi
• A novel mouse model of calcific aortic valve stenosis
• Assessment of the piroxicam-incited model of synchronized colitis in T-cell receptor alpha chain-deficient mice
• Hepatoprotective effect of Holothuria leucospilota methanolic extract on dimethyl nitrosamine–induced hepatotoxicity in rats
• An ethically guided preclinical device for phenotyping H₂ production in laboratory rodents
• Establishment and evaluation of an improved rat model of open abdomen
• Comparative studies between humans and golden Syrian hamsters via thromboelastography
• Influence of ear tags on the results of body composition analysis in mice
• Elimination of GGTA1, CMAH, β4GalNT2 and CIITA genes in pigs compromises human versus pig xenogeneic immune reactions